Clinical trial Recruiting at 1 site Interventional Ages 40 and up

Comparing cervical versus thoracic trans‑spinal magnetic stimulation added to brain TMS to improve walking in Parkinson's disease

Official title: Effects of the Stimulation Site of Trans-spinal Magnetic Stimulation Combined With Transcranial Magnetic Stimulation on Functional Mobility in Individuals With Parkinson's Disease

Run by Universidade Federal de Pernambuco · NCT07488026 · Data updated 2026-11-12

This trial will test whether adding cervical or thoracic trans‑spinal magnetic stimulation to repetitive brain TMS helps people with Parkinson's and gait problems walk better and move more easily.

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversidade Federal de Pernambuco
Academic / other
Locations1 site (Recife, Pernambuco)
StatusRecruiting
StartedJanuary 5, 2026
Main results expectedNovember 2026
Study endsDecember 2026
Registry record updatedMarch 23, 2026
Trial IDNCT07488026 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 40 or older with a neurologist‑confirmed Parkinson's diagnosis, stable dopaminergic medication for at least three months, disease stage about 2.5–3 on the modified Hoehn and Yahr scale, and at least one freezing‑of‑gait episode per week who have no contraindications to magnetic stimulation.

Probably not a fit

Patients with other neurological, vestibular, severe musculoskeletal or visual impairments, prior Parkinson's surgery, MoCA score under 21, a history of seizures, or metal implants in the neck or spine are unlikely to benefit or may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

People with Parkinson's disease and frequent freezing of gait are randomized to receive repetitive transcranial magnetic stimulation (rTMS) combined with either cervical or thoracic trans‑spinal magnetic stimulation (tsMS). Each participant completes a course of 10 treatment sessions and outcomes are measured before and after the intervention. Primary outcomes include functional mobility and gait speed, with secondary measures of motor function, freezing episodes, balance, quality of life, patient‑reported global improvement, and adverse events. The comparison aims to identify whether the site of tsMS application produces different effects on mobility and motor outcomes.

Why it matters

Potential benefit: If successful, this approach could identify the best spinal stimulation site to improve walking and reduce freezing in people with Parkinson's, leading to more effective adjunct treatments.

How similar studies have gone: Small studies have reported motor or gait benefits from rTMS or trans‑spinal stimulation alone, but directly comparing cervical versus thoracic tsMS combined with rTMS is relatively novel and not yet well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: (i) a clinical diagnosis of Parkinson's disease confirmed by a neurologist; (ii) stable dopaminergic pharmacological treatment for at least three months; (iii) age 40 years or older; (iv) disease stage between 2.5 and 3 on the modified Hoehn and Yahr scale; (v) (v) gait impairment, defined as the occurrence of at least one freezing of gait episode per week.

\-

Exclusion Criteria:

(i) other neurological disorders, orthostatic hypotension, vestibular, musculoskeletal, or visual impairments that could compromise performance on the proposed assessments; (ii) other osteomuscular conditions affecting the lower limbs that interfere with mobility and functional performance; (iii) a Montreal Cognitive Assessment (MoCA) score lower than 21 points; (iv) prior surgical procedures for Parkinson's disease; or (v) contraindications to magnetic stimulation techniques, including a history of seizures or the presence of metallic implants in the neck or spinal region.

Where it's running

  • Universidade Federal de Pernambuco
    Recife, Pernambuco, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.